Clinical Trial Update: Evaluation of the Diagnostic Performance of MRI±Biopsy to Optimize Resection of Ductal Carcinoma In Situ (DCIS) Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating MRI with or without biopsy to optimize surgical resection in ductal carcinoma in situ of the breast has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Ductal Carcinoma in Situ

Snippet

Sponsor: Gustave Roussy, Cancer Campus, Grand Paris | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED